Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.

Archives of medical research - 1 Jan 2000

Brites Fernando Daniel, Verona Julián, Schreier Laura Ester, Fruchart Jean-Charles, Castro Graciela Rosa, Wikinski Regina Luisa

Abstract excerpt

BACKGROUND: Previous studies have shown that high density lipoprotein (HDL)-deficient states are associated with reduced paraoxonase 1 (PON1) activity. However, HDL reduction caused by primary hypertriglyceridemia has not been fully explored. The aim of the present study was to evaluate whether PON1 and platelet-activating factor acetylhydrolase (PAF-AH), two antioxidant enzymes, were altered in patients with low...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 1-Alkyl-2-acetylglycerophosphocholine Esterase
Share to Antioxidants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aryldialkylphosphatase

Share to Cholesterol, HDL

Share to Cholesterol, LDL

Share to Hypertriglyceridemia

Share to Lipid Metabolism

Share to Lipoproteins

Source

Identifiers

PMID: 15163466
DOI: 10.1016/j.arcmed.2004.02.002

Genes

PON1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.PMID 15163466Read ↗

Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders.Semantic proximity Read ↗

Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme.Semantic proximity Read ↗

Paraoxonase 1 activity and phenotype distribution in premenopausal and postmenopausal women.Semantic proximity Read ↗

Paraoxonase (PON1) is associated with familial combined hyperlipidemia.Semantic proximity Read ↗

Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia.Semantic proximity Read ↗

Determinants of paraoxonase activity in healthy adults.Semantic proximity Read ↗

The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome.Semantic proximity Read ↗

The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.Semantic proximity Read ↗

Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.Semantic proximity Read ↗

The paraoxonase 1, 2 and 3 in humans.Semantic proximity Read ↗

Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia.Semantic proximity Read ↗

Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.